Standout Papers
- A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. (1994)
- A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. (1994)
Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
The IASP classification of chronic pain for ICD-11: chronic primary pain
2018 Standout
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
2008 Standout
Optimal approaches to data collection and analysis of potential immune mediated disorders in clinical trials of new vaccines
2013
Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study
2011
Risk factors for functional limitations in patients with long‐standing ankylosing spondylitis
2005
The role of the T cell in autoimmune inflammation.
2005
Open label trial of anakinra in active ankylosing spondylitis over 24 weeks
2004
A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis
2007
A six‐month randomized, controlled, double‐blind, dose‐response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug–refractory ankylosing spondylitis
2002
Towards the safer use of medicines
1995
Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial
2006 Standout
The X‐chromosome and susceptibility to ankylosing spondylitis
2000
Rheumatoid arthritis
2018 Standout
Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies
2014 Standout
Psoriasis
2009 Standout
Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: Evaluation of a new scoring system
2003
Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT)
2005
Changes Over Time in the Diagnosis of Rheumatoid Arthritis in a 10-year Cohort
2009
Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems
2004
Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor α blockers in ankylosing spondylitis
2004
When does rheumatoid arthritis begin and why do we need to know?
2000
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
2007 Standout
Maternal-Fetal Disparity in HLA Class II Alloantigens and the Pregnancy-Induced Amelioration of Rheumatoid Arthritis
1993
The bath ankylosing spondylitis radiology index (BASRI): A new, validated approach to disease assessment
1998
Successful Treatment of Recalcitrant Chronic Idiopathic Urticaria With Sulfasalazine
2006
Inflammatory back pain in ankylosing spondylitis: A reassessment of the clinical history for application as classification and diagnostic criteria
2006
Biannual Radiographic Assessments of Hands and Feet in a Three‐Year Prospective Followup of Patients with Early Rheumatoid Arthritis
1992
Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases
2011
Whole-Genome Screening in Ankylosing Spondylitis: Evidence of Non-MHC Genetic-Susceptibility Loci
2001
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Infliximab improves productivity and reduces workday loss in patients with ankylosing spondylitis: Results from a randomized, placebo‐controlled trial
2006
Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: Clinical and magnetic resonance imaging data
2005
Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis
2008
Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial
2006
Extraintestinal manifestations in inflammatory bowel disease
2005
Is disease severity in ankylosing spondylitis genetically determined?
2001
Psoriatic arthritis: epidemiology, clinical features, course, and outcome
2005 Standout
Conventional treatments for ankylosing spondylitis
2002
Five Years of GWAS Discovery
2012 Standout
Combined spa–exercise therapy is effective in patients with ankylosing spondylitis: a randomized controlled trial
2001
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Patient-assessed health in ankylosing spondylitis: a structured review
2005
Rheumatoid Arthritis
1990
Osteoporosis: now and the future
2011 Standout
Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial
2006
Assessment of enthesitis in ankylosing spondylitis
2003
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
2015 Standout
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Autologous hemopoietic stem cell transplantation. A possible cure for rheumatoid arthritis?
1997
Progress in the genetics of ankylosing spondylitis
2011
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
Comparison of statistically derived ASAS improvement criteria for ankylosing spondylitis with clinically relevant improvement according to an expert panel
2003
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
2009 Standout
Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis
2004
Six months open label trial of leflunomide in active ankylosing spondylitis
2004
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
2000 Standout
Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis
2005
Ankylosing spondylitis
2007 Standout
The Effect of Infliximab and Timing of Vaccination on the Humoral Response to Influenza Vaccination in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
2009
The balance of Th1/Th2 cytokines in rheumatoid arthritis
2001
Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients
2001
Efficacy of anakinra in active ankylosing spondylitis: a clinical and magnetic resonance imaging study
2004
Sulfasalazine for ankylosing spondylitis
2005
International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis
2003
PROGNOSIS, COURSE OF DISEASE, AND TREATMENT OF THE SPONDYLOARTHROPATHIES
1998
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial
2002 Standout
Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor α receptor fusion protein etanercept
2005
Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis
2009
Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis
2003
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Determinants of hyperkyphosis in patients with ankylosing spondylitis
2005
Development and preselection of criteria for short term improvement after anti-TNFα treatment in ankylosing spondylitis
2004
A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience
2003
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
2000 Standout
Atherosclerosis — An Inflammatory Disease
1999 Standout
Rheumatoid arthritis
2010 Standout
No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial
2006
Sex differences in autoimmune disease
2001 Standout
The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade(R))
2004
Successful treatment of active ankylosing spondylitis with the anti–tumor necrosis factor α monoclonal antibody infliximab
2000
The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general
2010 Standout
Suppression of bone formation by osteoclastic expression of semaphorin 4D
2011 Standout
Medication toxicity among patients with ankylosing spondylitis
2002
Adalimumab reduces spinal symptoms in active ankylosing spondylitis: Clinical and magnetic resonance imaging results of a fifty‐two–week open‐label trial
2006
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: A prospective, open-label, parallel-cohort, single-center study
2011
Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor α antibody infliximab
2005
Treatment of active psoriatic arthritis with the PPAR ligand pioglitazone: an open-label pilot study
2004
2‐Chloroadenosine but not adenosine induces apoptosis in rheumatoid fibroblasts independently of cell surface adenosine receptor signalling
2002 StandoutNobel
Persistent clinical response to the anti-TNF-α antibody infliximab in patients with ankylosing spondylitis over 3 years
2005
Cytokines in the pathogenesis of rheumatoid arthritis
2007 Standout
Quality criteria were proposed for measurement properties of health status questionnaires
2006 Standout
One‐year open‐label trial of thalidomide in ankylosing spondylitis
2002
ANKYLOSING SPONDYLITIS
1998
Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial
2003
Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis
2004
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
2012 Standout
Role of NOD2 variants in spondylarthritis
2002
Susceptibility to ankylosing spondylitis in twins the role of genes, HLA, and the environment
1997
Impaired Peripheral Th1 CD4+ T Cell Response to Escherichia coli Proteins in Patients with Crohn’s Disease and Ankylosing Spondylitis
2011
Treatment of Ankylosing Spondylitis by Inhibition of Tumor Necrosis Factor α
2002
Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab
2005
Guidelines of care for the management of psoriasis and psoriatic arthritis
2009
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis
2009 Standout
Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: A randomized clinical trial
2005
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Dickkopf-1 is a master regulator of joint remodeling
2007
Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: Results of a multicenter, randomized, double‐blind, placebo‐controlled magnetic resonance imaging study
2006
Assessments in ankylosing spondylitis
2006
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
What is the most appropriate radiologic scoring method for ankylosing spondylitis?
2004
Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity
2014
Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
2005
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Aortic root disease and valve disease associated with ankylosing spondylitis
1998
The role of inflammation in depression: from evolutionary imperative to modern treatment target
2015 Standout
Termination of disease-modifying antirheumatic drugs in rheumatoid arthritis and in psoriatic arthritis.
2003
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Symmetrical Erosive Peripheral Polyarthritis in the Late Archaic Period of Alabama
1988 Science
Distinctions Between Diagnostic and Classification Criteria?
2015
Fat and Beyond: The Diverse Biology of PPARγ
2008 Standout
Update on Spondyloarthropathies
2002
Primary Aldosteronism
1988
Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes.
2005
The interleukin (IL)-23/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment
2015
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
2016 Standout
Health-related quality of life in ankylosing spondylitis: A survey of 175 patients
1999
Efficacy of methotrexate in ankylosing spondylitis: a randomized, double blind, placebo controlled trial.
2004
Gold Nanoparticles: A Revival in Precious Metal Administration to Patients
2011 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
The Cochrane review of physiotherapy interventions for ankylosing spondylitis.
2005
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Impaired T cell receptor signaling and development of T cell–mediated autoimmune arthritis
2020 StandoutNobel
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
2020 Standout
Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
2011 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of A Cãlin being referenced
A prospective nationwide cross-sectional study of NSAID usage in 1331 patients with ankylosing spondylitis.
1990
Ankylosing spondylitis--an analytical review of 1500 patients: the changing pattern of disease.
1988
Lessons from an international survey of paper cases of 10 real patients from an early arthritis clinic. CRI (Club Rhumatismes et Inflammation) Group.
2001
Excess deoxycorticosterone secretion from adrenocortical carcinoma.
1974
Destructive arthritis, rheumatoid factor, and HLA–DR4. Susceptibility versus severity, a case–control study
1989
Sulfasalazine in the treatment of spondylarthropathy
1995
Impact of sex on inheritance of ankylosing spondylitis: a cohort study
1999
Seronegative Spondyloarthritides
1986
Socioeconomic status in ankylosing spondylitis: relationship between occupation and disease activity.
1997
Willingness to accept risk in the treatment of rheumatic disease.
1990
Exercise in ankylosing spondylitis: how much is optimum?
1998
Ankylosing spondylitis in women and men: a case-control study.
1983
Is there sexual inequality in ankylosing spondylitis? A study of 498 women and 1202 men.
1990
HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom.
1996
A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.
1994 Standout
A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index.
1994 Standout
Perception of prescription drug risks: a survey of patients with ankylosing spondylitis.
1990